title: Cystic fibrosis-related oxidative stress and intestinal lipid disorders.
abstract: CONCLUSIONS
  Cystic fibrosis (CF) is the most common lethal genetic disorder in the Caucasian people. It is due to the mutation of cystic fibrosis transmembrane conductance regulator (CFTR) gene located on the long arm of the chromosome 7, which encodes for CFTR protein. The latter, an adenosine triphosphate binding cassette, is a transmembrane chloride channel that is also involved in glutathione transport. As glutathione/glutathione disulfide constitutes the most important pool of cellular redox systems, CFTR defects could thus disrupt the intracellular redox balance. Resulting multisystemic diseases are essentially characterized by a chronic respiratory failure, a pancreatic insufficiency, an essential fatty acid deficiency (EFAD), and inadequate levels of antioxidant vitamins.
  
  
  BACKGROUND
  The pathophysiology of CF is complex; however, several mechanisms are proposed, including oxidative stress (OxS) whose implication is recognized and has been clearly demonstrated in CF airways.
  
  
  RESULTS
  Little is known about OxS intrinsic triggers and its own involvement in intestinal lipid disorders. Despite the regular administration of pancreatic supplements, high-fat high-calorie diets, and antioxidant fat-soluble vitamins, there is a persistence of steatorrhea, EFAD, and harmful OxS. Intriguingly, several trials with elevated doses of antioxidant vitamins have not yielded significant improvements.
  
  
  CONCLUSIONS
  The main sources and self-maintenance of OxS in CF should be clarified to improve treatment of patients. Therefore, this review will discuss the potential sources and study the mechanisms of OxS in the intestine, known to develop various complications, and its involvement in intestinal lipid disorders in CF patients.
authors.affiliation: 1 Research Centre, CHU Ste-Justine, Université de Montréal , Montréal, Quebec, Canada .
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Kleme
authors.forename: Emile
authors.initials: E
authors.lastname: Levy
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D003550:Cystic Fibrosis / Q000473:pathology*; D005227:Fatty Acids / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D007422:Intestines / Q000473:pathology*; D052439:Lipid Metabolism Disorders; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008168:Lung / Q000378:metabolism* / Q000473:pathology; D008928:Mitochondria / Q000378:metabolism; D018384:Oxidative Stress; D010179:Pancreas / Q000378:metabolism / Q000473:pathology; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000975:Antioxidants; D005227:Fatty Acids; D017382:Reactive Oxygen Species